Ruby Delgado

3.1k total citations
56 papers, 2.0k citations indexed

About

Ruby Delgado is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Ruby Delgado has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Hematology and 16 papers in Surgery. Recurrent topics in Ruby Delgado's work include Multiple Myeloma Research and Treatments (15 papers), Cutaneous Melanoma Detection and Management (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ruby Delgado is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Cutaneous Melanoma Detection and Management (7 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ruby Delgado collaborates with scholars based in United States, Mexico and Netherlands. Ruby Delgado's co-authors include Jorge Albores‐Saavedra, Frank Vuitch, Klaus J. Busam, David S. Klimstra, Daniel G. Coit, Sara Milchgrub, Douglas R. Gnepp, Kyle Molberg, Clara S. Heffess and Michael Z. Gilcrease and has published in prestigious journals such as Blood, Cancer and International Journal of Cancer.

In The Last Decade

Ruby Delgado

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruby Delgado United States 21 1.0k 948 479 312 305 56 2.0k
Tony W.H. Shek China 29 870 0.9× 617 0.7× 323 0.7× 247 0.8× 566 1.9× 108 2.4k
Norio Azumi United States 33 1.2k 1.1× 657 0.7× 544 1.1× 286 0.9× 598 2.0× 92 3.0k
Michael W. Stanley United States 28 986 1.0× 1.1k 1.2× 536 1.1× 80 0.3× 347 1.1× 79 2.1k
Lisa M. Rooper United States 31 1.4k 1.4× 1.4k 1.5× 494 1.0× 228 0.7× 520 1.7× 148 3.0k
Dominic V. Spagnolo Australia 31 734 0.7× 771 0.8× 456 1.0× 279 0.9× 615 2.0× 115 2.7k
Gordon H. Yu United States 19 500 0.5× 575 0.6× 333 0.7× 98 0.3× 313 1.0× 76 1.6k
Tsutomu Daa Japan 24 556 0.6× 642 0.7× 271 0.6× 79 0.3× 325 1.1× 156 1.9k
Jacqueline E. van der Wal Netherlands 39 1.3k 1.3× 1.5k 1.6× 289 0.6× 102 0.3× 325 1.1× 87 3.8k
Michael Michal Czechia 32 985 1.0× 1.2k 1.2× 164 0.3× 214 0.7× 608 2.0× 221 2.9k
J. Bosq France 28 1.2k 1.2× 657 0.7× 339 0.7× 382 1.2× 1.3k 4.4× 70 2.8k

Countries citing papers authored by Ruby Delgado

Since Specialization
Citations

This map shows the geographic impact of Ruby Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Delgado more than expected).

Fields of papers citing papers by Ruby Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Delgado. The network helps show where Ruby Delgado may publish in the future.

Co-authorship network of co-authors of Ruby Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Delgado. A scholar is included among the top collaborators of Ruby Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Delgado. Ruby Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srour, Samer A., Rima M. Saliba, Qaiser Bashir, et al.. (2020). Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple Myeloma. Transplantation and Cellular Therapy. 27(3). 243.e1–243.e6. 2 indexed citations
2.
Malek, Ehsan, Vinita Gupta, Richard J. Creger, et al.. (2018). Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Leukemia & lymphoma. 59(8). 1905–1912. 8 indexed citations
3.
Nieto, Yago, Benigno C. Valdez, Sai Ravi Pingali, et al.. (2017). High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. The Lancet Haematology. 4(6). e283–e292. 13 indexed citations
4.
Kayton, Mark L., Ruby Delgado, Klaus J. Busam, et al.. (2008). Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer. 112(9). 2052–2059. 40 indexed citations
5.
Dusza, Stephen W., et al.. (2007). Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases. Journal of the American Academy of Dermatology. 58(1). 142–148. 102 indexed citations
6.
Busam, Klaus J., et al.. (2006). Clusterin expression in primary and metastatic melanoma. Journal of Cutaneous Pathology. 33(9). 619–623. 15 indexed citations
7.
Sachs, Dana L., et al.. (2005). Virus-Associated Trichodysplasia Spinulosa. The American Journal of Surgical Pathology. 29(2). 241–246. 38 indexed citations
8.
Miner, Thomas J., Ruby Delgado, Klaus J. Busam, et al.. (2004). Primary vaginal melanoma: A critical analysis of therapy. Annals of Surgical Oncology. 11(1). 34–39. 59 indexed citations
9.
Reeves, Mark E., Ruby Delgado, Klaus J. Busam, Mary S. Brady, & Daniel G. Coit. (2003). Prediction of Nonsentinel Lymph Node Status in Melanoma. Annals of Surgical Oncology. 10(1). 27–31. 102 indexed citations
10.
Delgado, Ruby, Dennis H. Kraus, Daniel G. Coit, & Klaus J. Busam. (2003). Sentinel lymph node analysis in patients with sweat gland carcinoma. Cancer. 97(9). 2279–2284. 40 indexed citations
11.
Brooks, Ari D., Wilbur B. Bowne, Ruby Delgado, et al.. (2001). Soft Tissue Sarcomas of The Groin: Diagnosis, Management, and Prognosis. Journal of the American College of Surgeons. 193(2). 130–136. 27 indexed citations
12.
Grobmyer, Stephen R., Bryan M. Clary, Jonathan J. Lewis, et al.. (2001). Adult perineal sarcomas. Journal of Surgical Oncology. 77(2). 101–104. 10 indexed citations
13.
Gilcrease, Michael Z., Ruby Delgado, & Jorge Albores‐Saavedra. (1999). Intrasellar adenoid cystic carcinoma and papillary mucinous adenocarcinoma: Two previously undescribed primary neoplasms at this site. Annals of Diagnostic Pathology. 3(3). 141–147. 13 indexed citations
14.
Gilcrease, Michael Z., Ruby Delgado, Frank Vuitch, & Jorge Albores‐Saavedra. (1998). Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: A histopathologic and immunohistochemical comparison. Human Pathology. 29(12). 1451–1456. 78 indexed citations
15.
Molberg, Kyle, Clara S. Heffess, Ruby Delgado, & Jorge Albores‐Saavedra. (1998). Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region. Cancer. 82(7). 1279–1287. 133 indexed citations
16.
Delgado, Ruby, et al.. (1997). Signet-ring sinus histiocytosis. Cancer. 80(2). 277–285. 24 indexed citations
17.
Delgado, Ruby, David S. Klimstra, & Jorge Albores‐Saavedra. (1996). Low grade salivary duct carcinoma: A distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 78(5). 958–967. 136 indexed citations
18.
Blumberg, David, Jeffrey L. Port, Benny Weksler, et al.. (1995). Thymoma: A multivariate analysis of factors predicting survival. The Annals of Thoracic Surgery. 60(4). 908–914. 295 indexed citations
19.
Albores‐Saavedra, Jorge, Frank Vuitch, Ruby Delgado, Elizabeth L. Wiley, & Herbert K. Hagler. (1994). Sinus Histiocytosis of Pelvic Lymph Nodes after Hip Replacement. The American Journal of Surgical Pathology. 18(1). 83–90. 58 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony W.H. Shek Breakdown of academic impact, for papers by Norio Azumi Breakdown of academic impact, for papers by Michael W. Stanley Breakdown of academic impact, for papers by Lisa M. Rooper Breakdown of academic impact, for papers by Dominic V. Spagnolo Breakdown of academic impact, for papers by Gordon H. Yu Breakdown of academic impact, for papers by Tsutomu Daa Breakdown of academic impact, for papers by Jacqueline E. van der Wal Breakdown of academic impact, for papers by Michael Michal Breakdown of academic impact, for papers by J. Bosq
Rankless by CCL
2026